drugset / Trial / NCT00777127

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

NCT00777127

Phase 4 Completed 258 enrolled MEDA Pharma GmbH & Co. KG
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream or Solaraze® 3% gel on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period.

Timeline

Start
2008-12
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 0.5 g Topical
Subject Imiquimod Other / unclassified Topical

Indications